New Funding Awards December 2022

Sponsored Research

William Jones of Cardiology has received a sub-award through the The Task Force for Global Health for a project entitled "COVID-19 Electronic Health Data Initiative." Total funding will be $86,100.

Yongmei Liu of Cardiology has received an award from the National Institutes of Health for a project entitled "Common mechanistic biomarkers of vascular and neuro-degeneration." Total funding will be $3,859,530.

Thomas Leblanc of Cell Therapy has received an award from the Massachusetts General Hospital for a project entitled "NAVIGATE- DreAMLand." Total funding will be $349,995.

Luigi Racioppi of Cell Therapy has received a sub-award through the Columbia University for a project entitled "Mechanisms of myeloid cells dysregulation in radiation survivors." Total funding will be $161,000.

David D'Alessio of Endocrinology has received a sub-award through the University of North Carolina - Chapel Hill for a project entitled "Carolina Consortium for Diversity Career Development in Nutrition, Obesity, and Diabetes Research." Total funding will be $14,992.

Caroline Sloan of General Internal Medicine has received an award from the National Institutes of Health for a project entitled "Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools." Total funding will be $874,943.

Caroline Sloan of General Internal Medicine has received a sub-award through the University of Massachusetts Medical School for a project entitled "An out-of-pocket cost transparency tool to increase access to affordable medications for patients with multiple chronic conditions." Total funding will be $39,928.

Heather Whitson of Geriatrics has received an award from the Benter Foundation for a project entitled "2023 Symposium and Novel Research Awards for Alzheimer's Disease." Total funding will be $110,000.

Maria Blasi of Infectious Diseases has received a sub-award through the University of North Carolina - Chapel Hill for a project entitled "Role and Mitigation of Inflammasomes and Inflammation During COVID-19." Total funding will be $100,000.

Wendy Prudhomme - O'Meara of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "Once bitten: A longitudinal, observational study of successful malaria parasite transmission events between humans and mosquitos." Total funding will be $47,075.

Cameron Wolfe of Infectious Diseases has received a sub-award through the Vanderbilt University Medical Center for a project entitled "Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients." Total funding will be $39,526.

Myles Wolf of Nephrology has received an award from the National Institutes of Health for a project entitled "Tissue-Specific Regulation and Effects of CYP24A1." Total funding will be $2,659,882.

Alan Chen of Oncology has received an award from the Lung Cancer Initiative of North Carolina for a project entitled "Discovering Novel Tumor-Reactive Antibodies in Pembrolizumab-Treated NSCLC." Total funding will be $25,000.

Virginia Kraus of Rheumatology has received a sub-award through the University of North Carolina - Chapel Hill for a project entitled "Is the gut important in multiple joint osteoarthritis? A multimodal investigation in humans and pet dogs." Total funding will be $29,548.

Industry Sponsored Clinical Trials

Adrian Hernandez of Cardiology has received an award from Boehringer Ingelheim Pharmaceuticals, Inc. for a project entitled "CardioHealth Alliance Membership." Total funding will be $200,000.

Neha Pagidipati of Cardiology has received an award from Novartis Farmaceutica SA de CV for a project entitled "NOVA-LATAM Lipid Management - Industry." Total funding will be $740,111.

Nishant Shah of Cardiology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "REVEAL." Total funding will be $15,000.

Andrew Wang of Cardiology has received an award from Bristol-Myers Squibb Company for a project entitled "Discover- HCM." Total funding will be $653,321.

Lindsay Rein of Cell Therapy has received an award from Medical College of Wisconsin for a project entitled "MCW:Txt Free Remission After Combo Therapy with Rux Plus Tyrosine Kinase Inhibition in CP-CML Who Relapsed after TKI Discontination." Total funding will be $85,898.

John Strouse of Hematology has received a sub-award through Rhode Island Hospital for a project entitled "Hydroxyurea Pharmacokinetics and Pharmacodynamics in Adults with Sickle Cell Anemia." Total funding is yet to be determined.

Barbara Alexander of Infectious Diseases has received an award from Scynexis Inc for a project entitled "A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus Intravenous Echinocandin followed Oral Fluconanaz." Total funding will be $332,481.

Micah McClain of Infectious Diseases has received an award from Biomeme, Inc. for a project entitled "Project Addendum #5." Total funding will be $851,693.

Susan Dent of Oncology has received an award from AstraZeneca AB for a project entitled "A Phase 3 Open-label Trial of Neoadjuvant Trastuzumab Deruxtecan (T-DXd) Monotherapy or T-DXd followed by THP Compared to ddAC-THP in Participants with High-risk HER2-positive Early-stage Breast Cancer (DESTINY-Breast11)." Total funding will be $1,055,462.

Linda Sutton of Oncology has received an award from Celcuity for a project entitled "Phase 3, Open-Label, Randomized, Two-Part Study Comparing Gedatolisib in Combination with Palbociclib and Fulvestrant to Standard-of-Care Therapies in Patients with HR-Positive, HER2-Negative Advanced Breast Cancer." Total funding will be $244,841.

Michael Hershfield of Rheumatology has received an award from Chiesi USA, Inc for a project entitled "Non-Registry Agreement Clinical Trial." Total funding will be $398,308.

Jennifer Rogers of Rheumatology has received an award from Aurinia Pharmaceuticals, Inc for a project entitled "A prosepective Observational registry of patients treated with LUPKYNIS (voclosporin) in the US." Total funding will be $117,460.

 

 

 

 

 

 

Share